Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
暂无分享,去创建一个
C. Nadal | Cristina Santos | G. Cavaletti | C. Briani | A. Argyriou | H. Kalofonos | S. Videla | J. Bruna | P. Alberti | D. Cortinovis | J. Villoria | C. Plata-Salamán | R. Velasco | M. Sust | A. Vaqué | T. Klein